DYNLL2 Protein (AA 1-89) (His tag)
-
- Target See all DYNLL2 Proteins
- DYNLL2 (Dynein, Light Chain, LC8-Type 2 (DYNLL2))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 1-89
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This DYNLL2 protein is labelled with His tag.
- Application
- SDS-PAGE (SDS)
- Characteristics
- DYNLL2, 1-89aa, Human, His tag, E.coli
- Purity
- > 90 % by SDS - PAGE
- Top Product
- Discover our top product DYNLL2 Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/ml (determined by Bradford assay)
- Buffer
- Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 30% glycerol, 0.2M NaCl
- Storage
- 4 °C
-
- Target
- DYNLL2 (Dynein, Light Chain, LC8-Type 2 (DYNLL2))
- Alternative Name
- DYNLL2 (DYNLL2 Products)
- Synonyms
- DNCL1B Protein, Dlc2 Protein, RSPH22 Protein, dlc2 Protein, dncl1b Protein, 1700064A15Rik Protein, 6720463E02Rik Protein, C87222 Protein, DLC8 Protein, DLC8b Protein, dynein light chain LC8-type 2 Protein, dynein light chain LC8-type 2 S homeolog Protein, DYNLL2 Protein, dynll2.S Protein, dynll2 Protein, Dynll2 Protein
- Background
- Dynein light chain 2, cytoplasmic, also known DYNLL2, is a large protein complex composed of six distinct subunits and is responsible for most intracellular movement toward the minus ends of microtubules. Dyneins are multisubunit, high molecular weight ATPases that interact with microtubules to generate force by converting the chemical energy of ATP into the mechanical energy of movement. DYNLL2 is a highly conserved eukaryotic hub protein with dozens of binding partners and various functions beyond being a subunit of dynein and myosin Va motor proteins. Recombinant human DYNLL2 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Synonyms: Dynein light chain 2, LC8-type 2, Dlc2, DNCL1B, DLC8b. NCBI no.: NP_542408
- Molecular Weight
- 12.5 kDa (109aa), confirmed by MALDI-TOF
- Pathways
- M Phase
-